The impact of systemic infection on the progression of neurodegenerative disease
The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“peripheral insults that cause a systemic inflammatory response might affect ongoing inflammation in the CNS mainly by microglial activation, production of inflammatory molecules, as well as recruitment of peripheral immune cells into the brain, thus shaping a cerebral inflammatory milieu that may seriously affect neuronal function (50, 52, 53).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [50]
In the citing paper
“chronic systemic inflammation, mostly in the form of infections, has long been associated with behavioral alterations and cognitive dysfunction (50, 51).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [50]
In the citing paper
“Depending on the developmental trigger, altered priming can impair or enhance reactions to subsequent immune challenges224,225.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [225]
In the citing paper
“chronic systemic inflammation, mainly in the form of infections, has long been associated with behavioral alterations and cognitive dysfunction (264–266).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [265]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · cited 1×
“pl?P05067">APP ) with the Swedish double mutation under the control of the prion protein promoter (TgAPPsw/Tg2576; Ref”
BackgroundAxonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532 · cited 1×
“There is good evidence that the invading leucocytes secrete molecules that act as 'molecular scissors' to transect axons in the early stages of plaque formatio”
BackgroundTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507 · cited 1×
“65 ), or expressing the neuron-specific enolase promoter (APP23; Ref”
Background
Cited by
Items 201–300 of 435
Perry, V. H. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.08.004 · Cited by 55
Self-citationKercher, L. A., Favara, C., Chan, C., Race, R., & Chesebro, B. W. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63256-7 · Cited by 50
Kelley, K. W., O’Connor, J. C., Lawson, M. A., Dantzer, R., Rodriguez-Zas, S. L., & McCusker, R. H. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.02.003 · Cited by 49
“Inflammation can increase sensitivity of the brain to subsequent inflammatory stimuli (Perry et al., 2003).”
BackgroundGao, X., Hu, X., Qian, L., Yang, S., Zhang, W., Zhang, D., Wu, X., Fraser, A., Wilson, B., Flood, P. M., et al. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11031 · Cited by 49
“The impact of systemic infection on the progression of neurodegenerative diseases has been documented (Arai et al. 2006; Combrinck et al. 2002; Panitch 1994), and several circulating cytokines (interferon-γ and TNF-α) (Perry et al. 2003; Qin et al. 2007) have been proposed to be important mediators.”
BackgroundInfluentialLouboutin, J., Reyes, B. A. S., Agrawal, L., Bockstaele, E. J. V., & Strayer, D. S. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.11.004 · Cited by 48
Meagher, M. W., Johnson, R. R., Young, E. E., Vichaya, E. G., Lunt, S., Hardin, E. A., Connor, M. A., & Welsh, C. J. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.05.001 · Cited by 50
Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury
Glotfelty, E. J., Delgado, T. E., Tovar-y-Romo, L. B., Luo, Y., Hoffer, B. J., Olson, L., Karlsson, T. E., Mattson, M. P., Harvey, B. K., Tweedie, D., et al. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00003 · Cited by 48
Casaletto, K. B., Staffaroni, A. M., Elahi, F., Fox, E., Crittenden, P. A., You, M., Neuhaus, J., Glymour, M., Bettcher, B. M., Yaffe, K., et al. (2018) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.05.004 · Cited by 47
The Role of Pro-inflammatory Cytokines in Memory Processes and Neural Plasticity
Goshen, I., & Yirmiya, R. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50021-6 · Cited by 53
Bao, F., Omana, V. N., Brown, A. M., & Weaver, L. C. (2011) · Journal of Neurotrauma · doi:10.1089/neu.2011.2190 · Cited by 46
“The SIRS after central nervous system (CNS) trauma begins with an influx of leukocytes into the liver, secondary to hepatic chemokine expression that occurs within 2h of injury (Campbell et al., 2003,2005; Perry et al., 2003; Wilcockson et al., 2002).”
InfluentialZhang, R., Sun, L., Hayashi, Y., Liu, X., Koyama, S., Wu, Z., & Nakanishi, H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.028 · Cited by 44
“There is increasing evidence that neuroinflammation initiated by IL- 1β plays a key role in the pathogenesis of a number of acute and chronic neurological disorders including Alzheimer's disease, Parkinson's disease, stroke and sickness behavior (Perry et al., 2003; Allan et al., 2005).”
Mechanisms of Neurologic Failure in Critical Illness
Pustavoitau, A., & Stevens, R. D. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2007.11.004 · Cited by 48
“It has been postulated that the ongoing innate immune response present in the brains of patients who have chronic neurodegenerative processes is a form of ‘‘priming,’’ with systemic infectious or inflammatory events precipitating acute exacerbations in behavior and neuronal damage [128,129].”
BackgroundIs Delirium the Cognitive Harbinger of Frailty in Older Adults? A Review about the Existing Evidence
Bellelli, G., Moresco, R., Panina‐Bordignon, P., Arosio, B., Gelfi, C., Morandi, A., & Cesari, M. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00188 · Cited by 45
Murta, V., Farías, M. I., Pitossi, F. J., & Ferrari, C. C. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.11.023 · Cited by 47
“The fact that our model utilizes long term expression (days) pro-inflammatory stimulus is an advantage, since it better resembles what happens in patients undergoing relapses associated with systemic infections (Buljevac et al., 2002; Perry et al., 2003).”
BackgroundInfluentialThe Interaction of the Atm Genotype with Inflammation and Oxidative Stress
Yang, Y., Hui, C. W., Li, J., & Herrup, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085863 · Cited by 44
“It is also known that peripheral infection can initiate the synthesis of cytokines within the CNS [39,40] and an amplified cytokine and inflammatory response may lead to increased neuronal loss and functional deficits [41].”
BackgroundChallenges and directions for the pathogen hypothesis of Alzheimer’s disease
Robinson, S. R., Dobson, C. B., & Lyons, J. M. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.022 · Cited by 48
“A recent review noted that during systemic infections, cytokines and molecules associated with the infectious agent are released into the circulation and cross the blood–brain barrier where they can activate microglial cells [41].”
BackgroundMcCluskey, L., Campbell, S. J., Anthony, D. C., & Allan, S. M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.009 · Cited by 42
“Perry et al (2003) have found that microglia primed by neuronal damage can be subsequently stimulated to a heightened level of inflammatory response by ensuing CNS insult, thus leading to vastly exaggerated levels of neuronal death.”
Efficacy of Natural Compounds in Neurodegenerative Disorders
Srivastava, P., & Yadav, R. S. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_7 · Cited by 47
Redlich, S., Ribes, S., Schütze, S., & Nau, R. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-108 · Cited by 42
“The functional outcome of TLR-induced activation of microglia in the CNS depends on a subtle balance between protective and harmful effects [48-50].”
BackgroundGerashchenko, D., & Shiromani, P. J. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.016 · Cited by 42
Uchida, K. (2022) · Cells · doi:10.3390/cells11050919 · Cited by 43
“There is cumulative evidence on an innate immune response suggesting peripheral and central crosstalk in AD pathogenesis [47,48].”
BackgroundKosloski, L. M., Ha, D. M., Hutter, J. A. L., Stone, D. K., Pichler, M. R., Reynolds, A. D., Gendelman, H. E., & Mosley, R. L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06834.x · Cited by 40
“Furthermore, this mixed profile environment primes microglia for robust acute inflammatory responses upon subsequent exposures to LPS, marked by increased IL-1b, TNF-a and IL-6 production (Gao et al. 2003; Perry et al. 2003).”
BackgroundAbeta DNA Vaccination for Alzheimers Disease: Focus on Disease Prevention
Cribbs, D. H. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791012080 · Cited by 38
“In particular, the meningeal and cortical blood vessels in many AD patients have activated perivascular macrophages and astrocytes, which will become further activated by strong peripheral inflammatory events [57–60].”
BackgroundPang, H.-Y., Liu, G., & Liu, G.-T. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2008.29 · Cited by 39
Inflammation as a Possible Link Between Dyslipidemia and Alzheimer’s Disease
Oliveira, B. C. D. L., Bellozi, P. M. Q., Reis, H. J., & de Oliveira, A. C. P. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.012 · Cited by 43
Murta, V., & Ferrari, C. C. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.06.004 · Cited by 41
“Despite the important association between ubiquitous TNF-α increase and relapses, treatment of MS patients with TNF-α inhibitors resulted in the exacerbation of central lesions (reviewed in (Perry et al., 2003)).”
InfluentialSenescent accelerated prone 8 (SAMP8) mice as a model of age dependent neuroinflammation
Fernández, A., Quintana, E., Velasco, P., Moreno-Jimenez, B., de Andrés, B., Gaspar, M.-L., Liste, I., Vilar, M., Mira, H., & Cano, E. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02104-3 · Cited by 40
Salani, F., Sterbini, V., Sacchinelli, E., Garramone, M., & Bossù, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01768 · Cited by 37
“In fact, in the aging brain and more evidently in AD patients, microglia appear primed: they are activated, produce increased amounts of pro-inflammatory mediators and are more susceptible to central damage after peripheral insults (93, 94).”
BackgroundOpsahl, M. L., & Kennedy, P. G. E. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0316-7 · Cited by 37
“Viruses are the predominant candidates, and MS relapsing episodes are frequently preceded by common viral infections such as a cold [26].”
BackgroundNovel approaches for immunotherapeutic intervention in Alzheimer's disease
Vasilevko, V., & Cribbs, D. H. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.03.019 · Cited by 39
Experimental Traumatic Brain Injury Induces Bone Loss in Rats
Brady, R. D., Shultz, S. R., Sun, M., Romano, T., van der Poel, C., Wright, D. K., Wark, J. D., O'Brien, T. J., Grills, B. L., & McDonald, S. J. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2014.3836 · Cited by 38
Systemic microbial TLR2 agonists induce neurodegeneration in Alzheimer’s disease mice
Lax, N., Fainstein, N., Nishri, Y., Ben‐Zvi, A., & Ben‐Hur, T. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01738-z · Cited by 38
Park, J. K., Lee, K. J., Kim, J. Y., & Kim, H. (2021) · Psychiatry Investigation · doi:10.30773/pi.2020.0205 · Cited by 41
Trends in Cochlear Implant Complications
Causon, A., Verschuur, C. A., & Newman, T. A. (2013) · Otology & Neurotology · doi:10.1097/mao.0b013e31827d0943 · Cited by 36
“external to the cochlea and may parallel findings in other compartments of the central nervous system (24) where inflammation has been shown to drive neurodegenerative change.”
BackgroundSelf-citationDiet and Age Interactions with Regards to Cholesterol Regulation and Brain Pathogenesis
Uranga, R. M., & Keller, J. N. (2010) · Current Gerontology and Geriatrics Research · doi:10.1155/2010/219683 · Cited by 44
“It has been hypothesized that high cholesterol levels in plasma may cause cerebrovasculature dysfunction thus triggering the activation of perivascular microglia with scavenger functions in the brain [179].”
BackgroundMajde, J. A. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.02.023 · Cited by 35
“There is experimental [113, 114] and clinical [115] evidence showing that systemic inflammation intensifies brain inflammation, even if the systemic inflammation is asymptomatic [116] .”
Holguin, A., Frank, M. G., Biedenkapp, J. C., Nelson, K., Lippert, D. C., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.11.014 · Cited by 37
“Second, glia and other monocytes can exist in an activated “primed” state, without producing proinflammatory mediators (Perry et al., 2003).”
BackgroundAnkeny, D. P., & Popovich, P. G. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05458.x · Cited by 36
“showing that neurodegeneration is augmented by systemic infection (Perry et al., 2003).”
BackgroundResultA possible central mechanism in autism spectrum disorders, part 1.
Blaylock, R. L. (2008) · PubMed · Cited by 40
Lee, K. H., Kwon, D. E., Do Han, K., La, Y., & Han, S. H. (2020) · BMC Neurology · doi:10.1186/s12883-020-01776-3 · Cited by 35
Zhu, X., Huang, J., Wu, Y., Zhao, S., & Chai, X. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01165-5 · Cited by 34
Cortés, C. J., & Miguel, Z. D. (2022) · Brain Plasticity · doi:10.3233/bpl-220139 · Cited by 35
“Indeed, systemic inflammation has been linked to neuroinflammation and identified as a risk factor for neurodegenerative disease [20, 21].”
BackgroundAlam, M. S., Rallabandi, V. P. S., & Roy, P. K. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00094 · Cited by 37
Page, V. J., & Ely, E. W. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511997389 · Cited by 47
¿ Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis
Michelena, G., Casas, M., Eizaguirre, M. B., Pita, M. C., Cohen, L., Alonso, R. N., Garcea, O., & Silva, B. A. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103368 · Cited by 36
Drevets, D. A., Schawang, J. E., Dillon, M. J., Lerner, M. R., Bronze, M. S., & Brackett, D. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.529 · Cited by 33
“Additionally, expression of genes such as MHC class II and C1q likely represent activation of microglia (44).”
BackgroundCytokines, Sickness Behavior, and Depression
Dantzer, R., Bluthé, R.-M., Castanon, N., Kelley, K. W., Konsman, J. P., Layé, S., Lestage, J., & Parnet, P. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50019-8 · Cited by 45
Cognitive decline in heart failure: Biomolecular mechanisms and benefits of exercise
Maroofi, A., Moro, T., Agrimi, J., & Safari, F. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166511 · Cited by 35
Yang, Y., García-Cruzado, M., Zeng, H., Camprubí-Ferrer, L., Bahatyrevich-Kharitonik, B., Bachiller, S., & Deierborg, T. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.006 · Cited by 31
Prebiotics for depression: how does the gut microbiota play a role?
Yang, Y., Bi, Z., Zhang, S., Si, L., Liu, X., & Li, F. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1206468 · Cited by 39
“Nevertheless, sustained systemic inflammation, frequently precipitated by infectious agents, has been strongly linked with a range of behavioral and cognitive impairments (115, 116).”
BackgroundRole of LDL Cholesterol and Endolysosomes in Amyloidogenesis and Alzheimer’s Disease
Chen, X. (2014) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000236 · Cited by 30
Onoda, A., Kawasaki, T., Tsukiyama∥, K., Takeda, K., & Umezawa, M. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00092 · Cited by 31
“, 2017), traumatic injury (Chauhan, 2014), and infection (Perry et al., 2003; Rock et al., 2004) in the CNS.”
BackgroundActivation of neonatal microglia can be influenced by other neural cells
Turano, A., Lawrence, J. H., & Schwarz, J. M. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.07.052 · Cited by 29
“Unlike the transient changes in microglial function that result from an immune challenge in adulthood, activation of neonatal microglia can result in persistent changes in immature microglial function, making early development a sensitive period for microglial activation [4].”
BackgroundScabia, G., Testa, G., Scali, M., Turco, S. D., Desiato, G., Berardi, N., Sale, A., Matteoli, M., Maffei, L., Maffei, M., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.08.222 · Cited by 31
Klettner, A., Hamann, T., Schlüter, K., Lucius, R., & Roider, J. B. (2014) · Acta Ophthalmologica · doi:10.1111/aos.12472 · Cited by 33
“In these diseases, systemic infection may exacerbate disease progression, which has been linked to microglia activation (Perry et al. 2003; Perry 2010).”
BackgroundMicroglia in the normally aged hippocampus
Choi, J. H., & Won, M. (2011) · Laboratory Animal Research · doi:10.5625/lar.2011.27.3.181 · Cited by 34
“In the CNS, microglia are classified into ameboid, intermediate, ramified (resting), activated and phagocytic, depending on their morphology under normal and disease conditions [76-78].”
BackgroundInfluentialInflammatory Mediators in the Frontal Lobe of Patients with Mixed and Vascular Dementia
Mulugeta, E., Molina-Holgado, F., Elliott, M. S., Hortobagyi, T., Perry, R., Kalaria, R. N., Ballard, C. G., & Francis, P. T. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000118633 · Cited by 29
“Inflammatory mediators are readily produced in brain areas affected by chronic neurodegenerative conditions and are abundant associated with s-amyloid (As) deposits and neurofibrillary tangles in AD [ ,”
BackgroundJing, H., Hao, Y., Bi, Q., Zhang, J., & Yang, P. (2015) · Neuroscience Research · doi:10.1016/j.neures.2014.10.015 · Cited by 28
Animal Models Recapitulating the Multifactorial Origin of Tourette Syndrome
Macrì, S., Onori, M. P., Roessner, V., & Laviola, G. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-411546-0.00008-1 · Cited by 28
Machado, I., Schiöth, H. B., Lasaga, M., & Scimonelli, T. N. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.041 · Cited by 30
“…in humans with disorders such as depression (Young et al., 2014), neurodegenerative disorders like Alzheimer's disease (AD) and Parkinson's disease (Cacquevel et al., 2004; Decourt et al., 2017; Nagatsu and Sawada, 2005; Perry et al., 2003), and infectious diseases (Shapira-Lichter et al., 2008).”
BackgroundHigher Risk of Developing Sudden Sensorineural Hearing Loss in Patients With Chronic Otitis Media
Yen, Y.-C., Lin, C., Weng, S., & Lin, Y. (2015) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2015.102 · Cited by 29
Wu, Z., & Nakanishi, H. (2015) · Journal of Immunology Research · doi:10.1155/2015/471342 · Cited by 27
“It is well known that chronic systemic inflammation has causal links to neuroinflammation via the actons of systemically released proinflammatory mediators including IL-1β and that microglia are the primary brain cells responding to systemic inflammation [5, 6].”
BackgroundPhenome-wide examination of comorbidity burden and multiple sclerosis disease severity
Zhang, T., Goodman, M. O., Zhu, F., Healy, B. C., Carruthers, R. L., Chitnis, T., Weiner, H. L., Cai, T., Jager, P. L. D., Tremlett, H. L., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000864 · Cited by 27
“Furthermore, relapses associated with an infection might result in greater neurologic damage (relative to relapses without comorbid infections) and greater long-term severity.(25) Our study again highlights infections associated with MS severity, independent of age, while reaffirming the PheWAS approach.”
ResultXu, Y., Deng, X.-H., & Bentivoglio, M. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.07.002 · Cited by 26
An overview of stress and immunity.
Groër, M., Meagher, M. W., & Kendall-Tackett, K. A. (2010) · American Psychological Association eBooks · doi:10.1037/12065-001 · Cited by 32
“Recent evidence suggests that microglia may function as the shared cellular substrate mediating these priming effects of proinflammatory cytokines in the CNS (Cunningham et al, 2005; Frank et al, 2007; Nair & Bonneau, 2006; Perry et al, 2003).”
BackgroundLin, F., Yen, J.-L., Kuo, Y.-C., Kang, J., Cheng, Y., Huang, W., & Hsiao, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020410 · Cited by 26
“In additional, IL-1β- and TNF-α-mediated neuronal death was reported in acute CNS injury and chronic neurodegenerative disease [40].”
BackgroundZameer, S., Alam, M. M., Hussain, S., Vohora, D., Ali, J., Najmi, A. K., & Akhtar, M. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.04.010 · Cited by 27
Opsahl, M. L., & Kennedy, P. G. E. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.08.014 · Cited by 26
“Of these two biological candidate groups, viruses have been and remain the leading contenders and MS relapsing episodes are frequently preceded by common viral infections [4].”
BackgroundThe Immune System and the Developing Brain
Schwarz, J. M., & Bilbo, S. D. (2011) · Colloquium Series on The Developing Brain · doi:10.4199/c00045ed1v01y201110dbr004 · Cited by 32
Michalska, P., Buendía, I., Duarte, P., Fernández‐Mendívil, C., Negredo, P., Cuadrado, A., López, M. G., & Leon, R. M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104597 · Cited by 25
Tomobe, K., Fujii, H., Sun, B., Nishioka, H., & Aruoma, O. I. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.05.007 · Cited by 25
Braun, J. B. S., Ruchel, J. B., Adefegha, S. A., Coelho, A. P. V., Trelles, K. B., Signor, C., Rubin, M. A., de Oliveira, J. S., Dornelles, G. L., de Andrade, C. M., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.134 · Cited by 25
Septic encephalopathy in the elderly – biomarkers of potential clinical utility
Schütze, S., Drevets, D. A., Tauber, S. C., & Nau, R. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1238149 · Cited by 25
“Pathophysiological mechanisms have been discussed in detail in several recent publications (Perry et al., 2003; Tauber et al., 2017, 2021; Robba et al., 2018; Too et al., 2021; Sekino et al., 2022; Dumbuya et al., 2023; Barichello et al., 2023; Piva et al., 2023).”
BackgroundInfluentialN-3 polyunsaturated fatty acid and neuroinflammation in aging and Alzheimer's disease
Layé, S., Madore, C., St‐Amour, I., Delpech, J.-C., Joffre, C., Nadjar, A., & Calon, F. (2015) · Nutrition and Aging · doi:10.3233/nua-150049 · Cited by 25
“[9] Perry VH, Newman TA, Cunningham C.”
Normal and Pathological Aging: From Animals to Humans
Berchtold, N. C., & Cotman, C. W. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-422-3_1 · Cited by 26
Edler, M. K., Munger, E. L., Maycon, H., Hopkins, W. D., Hof, P. R., Sherwood, C. C., & Raghanti, M. A. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25167 · Cited by 23
Serna-Orozco, M. F., Mosquera, M., & García‐Perdomo, H. A. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08866-w · Cited by 25
“Studies in animal models have demonstrated that systemic infections can lead to cognitive impairment in individuals with neurological diseases and even in healthy adults (Perry et al., 2003).”
Vertebrate food products as a potential source of prion-like α-synuclein
Killinger, B. A., & Labrie, V. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0035-z · Cited by 25
Immunology primer for neurosurgeons and neurologists part 2: Innate brain immunity
Blaylock, R. L. (2013) · Surgical Neurology International · doi:10.4103/2152-7806.118349 · Cited by 27
Gaykema, R. P. A., Balachandran, M. K., Godbout, J. P., Johnson, R. W., & Goehler, L. E. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.07.005 · Cited by 28
“infection aggravates cognitive decline in Alzheimer's disease patients (Holmes et al., 2003; Perry et al., 2003).”
BackgroundLittrell, J. L. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00297 · Cited by 25
“Inoculation with typhoid proteins, which increases systemic levels of IL-6, similarly enhances activity of the insula and right anterior cingulate which correlate with subjective fatigue and confusion (Harrison et al., 2009).”
BackgroundInfluentialdel Palacio, J. P., Díaz, C., de la Cruz, M., Annang, F. B., Martín, J., Pérez‐Victoria, I., González-Menéndez, V., de Pedro, N., Tormo, J. R., Algieri, F., et al. (2016) · SLAS DISCOVERY · doi:10.1177/1087057116635517 · Cited by 22
“There is emerging evidence to support the idea that non-specific systemic infection or inflammation in people with existing inflammation in the brain contributes to the disease progression rate through further activation of these already primed macrophages.(30) Therefore, the use of a compound with both immunomodulato…”
BackgroundThe Effects of Immune System Modulation on Prion Disease Susceptibility and Pathogenesis
Mabbott, N. A., Bradford, B. M., Pal, R., Young, R. A., & Donaldson, D. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197299 · Cited by 22
“Infection of the brain with prions has been suggested to induce a “primed state” in the microglia that enables these cells to rapidly respond to subsequent exposure to pro-inflammatory stimuli [181].”
BackgroundPage, V. J., & Ely, E. W. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139924184 · Cited by 33
The Effects of Modified Curcumin Preparations on Glial Morphology in Aging and Neuroinflammation
Ullah, F., Gamage, R. V., Sen, M. K., & Gyengési, E. (2022) · Neurochemical Research · doi:10.1007/s11064-021-03499-4 · Cited by 22
Schütze, S., Ribes, S., Kaufmann, A., Manig, A., Scheffel, J., Redlich, S., Bunkowski, S., Hanisch, U., Brück, W., & Nau, R. (2014) · Oncotarget · doi:10.18632/oncotarget.2709 · Cited by 27
“TLR on microglia are stimulated during the early phase of CNS infections and systemic infections [23, 24, 13, 25].”
BackgroundCui, Z., Wang, P., Sun, L., Liu, H., Yang, J., Li, X., Kang, L., Huang, Y., Shen, A., & Cheng, C. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.04.009 · Cited by 21
Zhang, H., Wang, F.-W., Yao, L.-L., & Hao, A.-J. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/193 · Cited by 24
Diesselberg, C., Ribes, S., Seele, J., Kaufmann, A., Redlich, S., Bunkowski, S., Hanisch, U., Michel, U., Nau, R., & Schütze, S. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1209-2 · Cited by 21
“TLR on microglia are stimulated during the early phase of CNS infections and systemic infections [9, 10].”
Hasseldam, H., Rasmussen, R. S., & Johansen, F. F. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0707-3 · Cited by 22
“, microglia, through the choroid plexus and/or by direct transport across the blood-brain barrier [28, 33–35].”
Inflamación y enfermedad de Parkinson
Barcia, C., & Herrero, M. T. (2004) · Revista de Neurología · doi:10.33588/rn.3806.2004033 · Cited by 22
Schütze, S., Loleit, T., Zeretzke, M., Bunkowski, S., Brück, W., Ribes, S., & Nau, R. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120856 · Cited by 27
Systemic infections in multiple sclerosis and experimental autoimmune encephalomyelitis
Tauber, S. C., Nau, R., & Gerber, J. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701531227 · Cited by 20
“In comparison to the suspected degree of inflammation marked by gadolinium-enhancing lesions in MRI, analysis of microglia activation by a peripheral benzodiazepine binding site (PBBS) in positron-emission tomography (PET) of MS patients showed a much more widespread inflammatory activity not restricted to plaques but…”
BackgroundTsymbalyuk, O., Gerzanich, V., Simard, J. M., & Rathinam, C. V. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02609-5 · Cited by 20
“Furthermore, infections acquired after TBI may trigger pathophysiological sequelae and exacerbate neurodegeneration [63, 64], intracranial hypertension and an associated need for longer duration on mechanical ventilation [65–69].”
BackgroundEarly Life Stress, Neuroinflammation, and Psychiatric Illness of Adulthood
Shin, S. H., & Kim, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_6 · Cited by 20
Targeting cytokine expression in glial cells by cellular delivery of an NF-κB decoy
Fisher, L., Samuelsson, M., Jiang, Y., Ramberg, V., Figueroa, R., Hallberg, E., Langel, Ü., & Iverfeldt, K. (2007) · Journal of Molecular Neuroscience · doi:10.1385/jmn:31:03:209 · Cited by 19
Gaviglio, E. A., Ramos, J. M. P., Arroyo, D. S., Bussi, C., Iribarren, P., & Rodriguez‐Galán, M. C. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108546 · Cited by 18
Nutritional quality and acceptability of Buddleja saligna herbal tea
Moodley, T., Amonsou, E. O., & Kumar, S. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-015-1870-8 · Cited by 21
“The leaves ofBuddleja species have been reported to be useful in treatment of neurodegenerative diseases (Perry et al. 2003).”
Towriss, M., MacVicar, B. A., & Ciernia, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108967 · Cited by 20
Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
Zhang, Y., Mo, C., Ai, P., He, X., Xiao, Q., & Yang, X. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2454937 · Cited by 20
“61 Bacterial translocation, a known complication of SIBO, can potentially lead to mucosal immune activation, 66 and the peripheral inflammatory states can trigger microglial activation, thereby exacerbating the existing neurodegenerative processes and motor fluctuations in PD. 67,68”
Metadata
- Authors
- Perry, V. H., Newman, T. A., & Cunningham, C.
- Affiliations
- University of Southampton (GB)
- Corresponding author
- Perry, V. Hugh
- Venue
- Nature Reviews Neuroscience
- Published
- 2003-02
- Volume
- 4
- Issue
- 2
- Pages
- 103-112
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2081655354
- Cited by
- 428
- References
- 108
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 6 · 2023: 11 · 2022: 12 · 2021: 14 · 2020: 18 · 2019: 13 · 2018: 17 · 2017: 14 · 2016: 20 · 2015: 21 · 2014: 24 · 2013: 24 · 2012: 20
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- systemic infection, neurodegenerative disease progression, multiple sclerosis, microglial activation, macrophages, neuroinflammation, myelin damage, T cells, neuropathology, disease progression
- MeSH terms
- Animals, Encephalitis, Humans, Infections, Macrophage Activation, Macrophages, Multiple Sclerosis, T-Lymphocytes, Microglia, Disease Progression, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.